Thursday, July 03, 2025

GET OUR FREE E-NEWSLETTER

“You may choose to look the other way, but you can never say again that you did not know.”

— William Wilberforce

Search

Glenmark Pharmaceuticals Recalls 1.5 Million Bottles of Generic ADHD Drug

by Rishma Parpia
ADHD medications
Glenmark Pharmaceuticals, Inc., a subsidiary of Glenmark Pharmaceuticals Ltd. of Mumbai, India, is recalling 1.476 million bottles of a generic Attention Deficit ...

Makers of Experimental COVID-19 Vaccines Lobby EU for Liability Protection

by TVR Staff
umbrella protection
Vaccines Europe, a pharmaceutical industry lobbying group, has issued a memo to its member companies saying it would seek liability ...

Novartis Pays $678 Million for Kickbacks to Doctors

by Rishma Parpia
doctor receiving cash
Novartis Pharmaceuticals Corp. of East Hanover, New Jersey has agreed to pay $678 million to settle a civil fraud lawsuit ...

Genetically Engineered Cow Plasma Therapy for COVID-19 Will Be Tested on Humans

by Rishma Parpia
three cute cows
Story Highlights Human trials for a new COVID-19 immunotherapy candidate (SAB-185) that is derived from genetically engineered cow plasma will ...

Rapid Tests for Coronavirus Raise Concerns Over Accuracy

by Marco Cáceres
confused woman staring at paper
On Mar. 27, 2020, the U.S. Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) to pharmaceutical and medical ...

Anti-Depressants in Short Supply During COVID-19 Lockdowns

by Rishma Parpia
pills in hand
Drug shortages listed by the U.S Food and Drug Administration (FDA) are exposing some of the ramifications of responses to ...

Poll Finds Only Half of Americans Plan to Get COVID-19 Vaccine

by TVR Staff
refusing vaccine
A recent poll conducted by the Associated Press's NORC Center for Public Affairs Research found that 20 percent of Americans ...

COVID-19 Related Drug Shortage in U.S. Because China Supplies Most Ingredients

by Rishma Parpia
drugs from China
Story Highlights The FDA has reported its first drug shortage as a result of the COVID-19 outbreak in China. Many ...

Chinese Pharmaceutical Industry Competes for Vaccine Market Share

by Kate Raines
Chinese vaccine researcher
China’s National Medical Products Administration has announced that two Chinese pharmaceutical companies, Walvax Biotechnology and Innovax, have been approved to ...

In this section

Search in Archive

Search in Site

To search in site, type your keyword and hit enter

Search
The Vaccine Reaction
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.